Effects of semaglutide on obstructive sleep apnea risk and outcomes in patients with obesity [0.03%]
司美格鲁肽对肥胖患者阻塞性睡眠呼吸暂停风险和结局的影响
Jheng-Yan Wu,Yu-Min Lin,Wan-Hsuan Hsu et al.
Jheng-Yan Wu et al.
Objectives: This study investigates the impact of semaglutide on obstructive sleep apnea (OSA) risk and clinical outcomes in individuals with obesity. Met...
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial [0.03%]
新诊断的鸟分枝杆菌复合体肺病（ARISE）中阿米卡星脂质体吸入混悬液的六月双盲活性对照试验
Charles L Daley,Jakko van Ingen,James D Chalmers et al.
Charles L Daley et al.
Rationale: Guidelines recommend amikacin liposome inhalation suspension (ALIS) for refractory Mycobacterium avium complex lung disease (MACLD) treatment, alongside other antibiotics. Efficacy of ALIS on microbiological en...
Randomized Controlled Trial
Annals of the American Thoracic Society. 2026 Apr 1;23(4):536-547. DOI:10.1093/annalsats/aaoaf064 2026
Correlation of ventilation-perfusion mismatch with hemodynamics in chronic thromboembolic pulmonary hypertension: a quantitative V/Q SPECT analysis [0.03%]
慢性肺血栓栓塞性肺动脉高压通气/灌注缺损与循环的关系：定量V/Q显像分析
Tilmann Kramer,Henning Weis,Merve Kural et al.
Tilmann Kramer et al.
The minimal important deterioration of the incremental shuttle walk test in chronic obstructive pulmonary disease: a prospective cohort study [0.03%]
慢性阻塞性肺疾病患者 Incremental Shuttle Walk Test 重要恶化最小差值的前瞻性队列研究
Timothy O Jenkins,George D Edwards,Suhani Patel et al.
Timothy O Jenkins et al.
Additive lung cancer risk in combined interstitial lung abnormalities and emphysema: Korean national lung cancer screening program [0.03%]
韩国全国肺癌筛查项目中联合肺间质病变与肺气肿的叠加性肺癌风险研究
Hyungjin Kim,Jong Hyuk Lee,Eunseo Jo et al.
Hyungjin Kim et al.
Rationale: Interstitial lung abnormalities (ILAs) and emphysema are frequently detected during lung cancer screening (LCS), but the impact of their coexistence-termed combined ILA and emphysema (CILAE)-on lung cancer risk...
Race-neutral spirometry reference equations change the interpretation of tests in South East Asian and Black pediatric patients [0.03%]
种族中立的肺活量测定参考方程改变了东南亚和黑人儿童患者的检测结果解释
Josie Chrenek,Akshdeep Sandhu,Jasneet Dhillon et al.
Josie Chrenek et al.
Rationale: The 2012 Global Lung Function Initiative (GLI) spirometry reference equations rely on race to predict pulmonary function, which may disproportionately affect diagnosis and management of respiratory conditions i...
Feasibility and reliability of home spirometry in lymphangioleiomyomatosis [0.03%]
家庭肺功能测定在淋巴管肌瘤病中的可行性和可靠性研究
Abhishek Singla,Oliveira A G Darkwah,Rhonda D Szczesniak et al.
Abhishek Singla et al.
Association between metered-dose inhaler confidence and misuse among adults with asthma or chronic obstructive pulmonary disease [0.03%]
关于哮喘或慢性阻塞性肺疾病成人患者定量吸入器信心与误用之间的关系
Nadia Liyanage-Don,Paulina Zajac,Andrea Jackson-Sagredo et al.
Nadia Liyanage-Don et al.
Summary for Clinicians: Clinical Practice Guideline for the Diagnosis and Management of Community-acquired Pneumonia [0.03%]
社区获得性肺炎的诊断和治疗临床实践指南（供临床医师使用）小结
Ioannis Konstantinidis,Barbara E Jones,Julio Ramirez et al.
Ioannis Konstantinidis et al.
Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease [0.03%]
慢性阻塞性肺疾病患者心血管风险预测工具的效果评估
Samaneh Salimian,Nathaniel M Hawkins,Joseph Emil Amegadzie et al.
Samaneh Salimian et al.
Rationale: Emerging evidence suggests that a widely-used risk scoring tool, QRISK3, substantially underestimates cardiovascular disease risk in patients with chronic obstructive pulmonary disease (COPD), raising concerns ...